Study to Assess the Efficacy and Safety of Garetosmab in Japanese Adult Patients With Fibrodysplasia Ossificans Progressiva (FOP)
Conditions: Fibrodyplasia Ossificans Progressiva (FOP); Heterotopic Ossification (HO) Intervention: Drug: garetosmab Sponsor: Regeneron Pharmaceuticals Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials